Power Law company profile

WuXi Biologics

Biotech & Life Sciences · Xuancheng, China · Founded 2000 · IPO 2017 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$15B

Market cap · Apr/2026

Revenue

$3.00B

Latest reported FY

Investors

1 investor on WuXi Biologics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage

Dinghang Capital

Global footprint

Where WuXi Biologics has talent and traffic

AI talent share

0.0% of workforce is AI talent
(1 of 2,990 staff)

Core AI00%

Other AI10.03%

Non-AI workforce2,98999.97%

Web traffic by country

180K monthly visits
across markets

🇨🇳 China90.2%

🇺🇸 United States10.4%

🏳️ Korea1.8%

🏳️ Republic of1.6%

🇬🇧 United Kingdom1.1%

Top 5 markets shown

Patent intelligence

$112M patent portfolio · 318 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$112M

0.74% of market cap · 4.8× the top peer BillionToOne ($24M)

318 active patent families

Where WuXi Biologics innovates Molecular biologyAntiendomysial antibodiesExpression vectorBiochemistryImmunology

Above peer median on Economic, Technology · Below peer median on Strategic, Market

Quality vs same-sector peers

WuXi Biologics on the five Patsnap quality dimensions

WuXi Biologics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where WuXi Biologics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across WuXi Biologics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See WuXi Biologics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo